Translational readthrough induction of pathogenic nonsense mutations.

Eur J Med Genet 2006 Nov-Dec;49(6):445-50. Epub 2006 May 19.

Department of Medical Genetics and Child Development, University of Pécs, József A. u. 7., 7623 Pécs, Hungary.

The treatment of genetic disorders is one of the biggest challenges lying ahead of modern medicine. While major advancements have been made in gene therapy, it is still far from achieving clinical success. However, other potential methods for treating single gene related diseases have also emerged recently. One such approach is the suppression of pathogenic nonsense mutations through inducing translational readthrough of the in-frame premature stop mutation. Aminoglycosides were the first drugs that gave promising results in this respect. This report provides a brief overview on the past, present and potential future of this pharmacogenetic approach.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2006.04.003DOI Listing
February 2007
3 Reads

Publication Analysis

Top Keywords

pathogenic nonsense
8
nonsense mutations
8
translational readthrough
8
single gene
4
gene diseases
4
emerged approach
4
suppression pathogenic
4
approach suppression
4
treating single
4
diseases emerged
4
methods treating
4
therapy achieving
4
gene therapy
4
achieving clinical
4
clinical success
4
potential methods
4
mutations inducing
4
in-frame premature
4
report overview
4
respect report
4

Altmetric Statistics

Similar Publications